Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Treatment Outcome
100%
Treatment Sequence
100%
Decision Model
100%
Advanced Melanoma
100%
Treatment Effect
57%
Treatment Duration
57%
Health Benefits
42%
Prognostic Factors
42%
Melanoma
42%
Long-term Health
42%
BRAF mutation
42%
Randomized Controlled Trial
28%
Systemic Treatment
28%
Life Expectancy
28%
Disease Progression
28%
Future Decisions
28%
Clinical Practice
14%
Patient Benefit
14%
Patient Characteristics
14%
Targeted Therapy
14%
Treatment Efficacy
14%
Relative Effectiveness
14%
Meta-analysis of Randomized Controlled Trials
14%
Targeted Immunotherapy
14%
Network Meta-analysis
14%
Starting Treatment
14%
Treatment Progression
14%
Relative Treatment Effect
14%
Time to Next Treatment
14%
Progression Time
14%
Semi-Markov Model
14%
INIS
data
100%
melanomas
100%
patients
71%
mutations
42%
diseases
28%
therapy
28%
mortality
14%
range
14%
decision making
14%
markov process
14%
lifetime
14%
time dependence
14%
immunotherapy
14%
Pharmacology, Toxicology and Pharmaceutical Science
Melanoma
100%
Randomized Controlled Trial
50%
Disease Exacerbation
33%
Life Expectancy
33%
Systemic Treatment
33%
Immunotherapy
16%
Psychology
Decision Model
100%
Decision Making
20%
Meta-Analysis
20%
Markov Model
20%
Economics, Econometrics and Finance
Causality Analysis
100%
Life Cycle
40%
Markov Model
20%